Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,109,813 papers from all fields of science
Search
Sign In
Create Free Account
Mammary Neoplasms
Known as:
breast tumours
, Neoplasia of the breast
, mammary tumor
Expand
A benign or malignant neoplasm of the breast parenchyma. It can originate from the ducts, lobules or the breast adipose tissue. Breast neoplasms are…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
1 ML Leuprolide Acetate 7.5 MG/ML Prefilled Syringe [Lupron]
10 ML Idarubicin Hydrochloride 1 MG/ML Injection
84 HR Estradiol 0.00313 MG/HR Transdermal System [Vivelle]
Animal Mammary Neoplasms
Expand
Narrower (4)
Malignant neoplasm of breast
Malignant neoplasm of female breast
Papillomatosis, florid, of nipple
breast metastasis
Broader (1)
Neoplasms
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
Tiffany M. Phillips
,
W. McBride
,
F. Pajonk
Journal of the National Cancer Institute
2006
Corpus ID: 11332552
BACKGROUND If cancer arises and is maintained by a small population of cancer-initiating cells within every tumor, understanding…
Expand
Review
2005
Review
2005
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
G. Lyman
,
A. Giuliano
,
+17 authors
E. Winer
Journal of Clinical Oncology
2005
Corpus ID: 9887177
PURPOSE To develop a guideline for the use of sentinel node biopsy (SNB) in early stage breast cancer. METHODS An American…
Expand
Review
2005
Review
2005
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
E. Leslie
,
R. Deeley
,
S. Cole
Toxicology and Applied Pharmacology
2005
Corpus ID: 31699962
Highly Cited
2003
Highly Cited
2003
BMC Cancer
A. P. Ortiz
,
Javier Pérez
,
+20 authors
Rico
2003
Corpus ID: 215527170
Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine…
Expand
Highly Cited
2003
Highly Cited
2003
Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine
A. Clarke
,
Janet K Shim
,
L. Mamo
,
J. Fosket
,
J. Fishman
American Sociological Review
2003
Corpus ID: 3947895
The first social transformation of American medicine institutionally established medicine by the end of World War II. In the next…
Expand
Highly Cited
1999
Highly Cited
1999
Cancer risks in BRCA2 mutation carriers.
H. Olsson
Journal of the National Cancer Institute
1999
Corpus ID: 31162194
BACKGROUND Carriers of germline mutations in the BRCA2 gene are known to be at high risk of breast and ovarian cancers, but the…
Expand
Highly Cited
1995
Highly Cited
1995
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D. Easton
,
D. Ford
,
D. Bishop
American Journal of Human Genetics
1995
Corpus ID: 19340973
Dominant predisposition to early-onset breast cancer and/or ovarian cancer in many families is known to be the result of germ…
Expand
Highly Cited
1994
Highly Cited
1994
Risks of cancer in BRCA1-mutation carriers
D. Ford
,
D. Easton
,
D. Bishop
,
S. Narod
,
D. Goldgar
The Lancet
1994
Corpus ID: 8338383
Highly Cited
1985
Highly Cited
1985
Risk factors for breast cancer in women with proliferative breast disease.
W. Dupont
,
D. Page
New England Journal of Medicine
1985
Corpus ID: 20498242
To assess the importance of various risk factors for breast cancer in women with benign proliferative breast lesions, we…
Expand
Highly Cited
1957
Highly Cited
1957
Histological Grading and Prognosis in Breast Cancer
H. Bloom
,
W. W. Richardson
British Journal of Cancer
1957
Corpus ID: 2746680
ImagesFigs. 19-24Figs. 7-12Figs. 1-6Figs. 13-18Figs. 33-36Figs. 25-29
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE